News & Press: Latest News

MDMA Announces New Vice President and General Counsel

Monday, April 4, 2016  
Share |

MDMA Announces New Vice President and General Counsel

Carolyn Bruguera brings over 22 years of industry and legal expertise  

WASHINGTON, DC – The Medical Device Manufacturers Association (MDMA) announced today that Carolyn Bruguera joined the organization as Vice President and General Counsel, building on MDMA’s resources for the growing legal complexities facing medical technology innovators. 

“Carolyn has an extensive background in dealing with the diverse legal challenges facing our industry, and she will be a tremendous asset to our members as they deal with compliance, post-market challenges, policy issues and more,” said Mark Leahey, President and CEO of MDMA. 

Carolyn M. Bruguera has extensive experience in the management of legal and compliance issues for medical device manufacturers. She previously served as General Counsel to Hansen Medical, Inc., a manufacturer of robots for intravascular procedures, and to Micrus Endovascular, a manufacturer of neurovascular devices which was acquired by Johnson & Johnson.  Carolyn received her undergraduate degree from Harvard University and her law degree from the University of California, Berkeley’s Boalt Hall School of Law.  

“MDMA’s members are developing the cures and therapies of tomorrow. I look forward to helping them understand and address the myriad legal and compliance challenges they face as they seek to bring life-changing technologies to patient and providers,” said Bruguera.  “I’m excited to join the MDMA team and help build on their proud tradition as the voice of innovative and entrepreneurial companies.”